ERYTECH provides financial update for Q3 2013 admERY November 5, 2013 Newsroom ERYTECH announces today its cash position and its revenues for the third quarter of 2013. You Might Also Like ERYTECH announces ADR Level 1 listing in the US January 12, 2015 ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States May 13, 2019 ERYTECH to Hold Q3 2016 Business Update Conference Call on November 4th, 2016 October 26, 2016
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States May 13, 2019
